Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22 | Zendy

Hyun Ae Jung | Zendy; Min Hee Hong | Zendy; Hyun Woo Lee | Zendy; Kyung Hee Lee | Zendy; Il Hwan Kim | Zendy; Young Joo Min | Zendy; Hee Kyung Ahn | Zendy; Byoung Yong Shim | Zendy; Yoon Hee Choi | Zendy; YunGyoo Lee | Zendy; JeongAh Kim | Zendy; Joung Soon Jang | Zendy; Seong Hoon Shin | Zendy; Keon Uk Park | Zendy; Jin Hyoung Kang | Zendy; Keunchil Park | Zendy

Open Access

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22

Author(s) -

Hyun Ae Jung,

Min Hee Hong,

Hyun Woo Lee,

Kyung Hee Lee,

Il Hwan Kim,

Young Joo Min,

Hee Kyung Ahn,

Byoung Yong Shim,

Yoon Hee Choi,

YunGyoo Lee,

JeongAh Kim,

Joung Soon Jang,

Seong Hoon Shin,

Keon Uk Park,

Jin Hyoung Kang,

Keunchil Park

Publication year - 2022

Publication title -

translational lung cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.474

H-Index - 41

eISSN - 2226-4477

pISSN - 2218-6751

DOI - 10.21037/tlcr-22-79

Subject(s) - afatinib , medicine , t790m , osimertinib , lung cancer , cohort , oncology , resistance mutation , confidence interval , cancer , epidermal growth factor receptor , surgery , erlotinib , gefitinib , biochemistry , chemistry , gene , reverse transcriptase , rna

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research